Central Admixture Pharmacy Services Inc recalls fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 50 mL, Total fentaNYL 75 mcg/50 m
Recalled October 11, 2023 · FDA recall D-0015-2024 · Central Admixture Pharmacy Services
Hazard
Lack of assurance of sterility: · FDA Class II
Units
895 50 mL syringes
Sold at
Nationwide in the USA
Description
Lack of assurance of sterility:
Product
fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 50 mL, Total fentaNYL 75 mcg/50 mL, 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2080-2
Manufacturer(s)
Central Admixture Pharmacy Services Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →